Kızılay, T. Et Al. 2024. Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study. European Neurology , vol.87, no.4 , 203-210.

Kızılay, T., Akbayir, E., Erol, R., Demir, A. S., Özkan Yaşargün, D., Yilmaz, V., ... Tuzun, E.(2024). Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study. European Neurology , vol.87, no.4, 203-210.

Kızılay, Tuğçe Et Al. "Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study," European Neurology , vol.87, no.4, 203-210, 2024

Kızılay, Tuğçe Et Al. "Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study." European Neurology , vol.87, no.4, pp.203-210, 2024

Kızılay, T. Et Al. (2024) . "Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study." European Neurology , vol.87, no.4, pp.203-210.

@article{article, author={Tuğçe Kızılay Et Al. }, title={Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study}, journal={European Neurology}, year=2024, pages={203-210} }